All In MedTech

Device Trial Radar · NCT07654491

Withings HFRN Retrospective Study

Validation of the Withings Heart Function Risk Notification (HFRN)

Last checked: Nov 20, 2026Latest source record: Jul 1, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

9,000

Planned (sponsor's estimate)

Start

Jun 2026

Primary completion

Sep 2026

Study completion Sep 2026

Sponsor

Lead sponsor
WithingsNot on our public-company list
Sponsor type
Industry
First posted
Jun 17, 2026

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 45 years, up to 120 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This is a fully decentralized retrospective, non-interventional study evaluating the diagnostic performance of the Withings Heart Function Risk Notification (HFRN), a software-only medical device (SaMD)

Conditions

  • Heart Failure

Interventions

  • Withings Heart Function Risk Notification (HFRN)Device

    Software-only medical device (SaMD)

  • Claims-based heart-failure adjudication (reference standard)Other

    Ground-truth heart-failure case / control status derived from administrative claims by a deterministic, pre-specified rule set.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Sensitivity (Se) of the HFRN algorithmTime frame: 13 weeks
  2. Specificity (Sp) of the HFRN algorithmTime frame: 13 weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Withings (Sponsor) - Decentralized Retrospective Study, No Physical Sites

    Issy-les-Moulineaux, Île-de-France Region, France

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.